News

Is Lucid Eating Tesla's Lunch?
Where there's smoke, there's fire, and it's clear that Tesla has hit a speed bump due to previously mentioned developments.
Lucid Diagnostics stock falls after pricing capital raise of $15M via stock offering
Lucid Diagnostics (LUCD) has announced the pricing of a public offering of 12.5 million shares of its common stock at $1.20 per share, for gross proceeds of approximately $15 million.
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced the ...
Lucid Diagnostics announces proposed public offering of common stock
Lucid Diagnostics (LUCD) intends to offer shares of common stock through an underwritten public offering. The company also plans to grant the underwriters a 45- ...
Lucid Diagnostics announces common stock offering, no amount given
Lucid Diagnostics (LUCD) announced its intention to offer shares of common stock through an underwritten public offering. Proceeds from the ...
StockStory.org on MSN14h
Lucid (LCID) and American Airlines (AAL), Delta Air Lines (DAL), Ford (F), Rivian (RIVN) Shares Are Soaring, What You Need To Know
What Happened? A number of stocks jumped in the afternoon session after markets rallied sharply on news that President Trump ...